The government has decided to restrict the entry of international students departing from countries with widespread Covid-19 variants until the nation vaccinates 70 percent or more of the population.It will also require all international students to undergo at least three polymerase chain reaction (
The U.S. Food and Drug Administration has revised its emergency use authorization (EUA) for Lilly’s baricitinib and authorized it as a Covid-19 treatment.Baricitinib, developed by Eli Lilly as a treatment for rheumatoid arthritis, is sold under the brand name Olumiant. The FDA granted EUA for the co
A research team at Korea University Guro Hospital has discovered a biomarker that can diagnose nonalcoholic steatohepatitis (NASH) using serum microRNA (miRNA).NASH is a disease that occurs in about 25 percent of patients with nonalcoholic fatty liver disease. Unlike simple fatty liver, the disease
Researchers at the Korea Institute of Science and Technology (KIST) have succeeded in developing a biosensor source technology that improves sensitivity by increasing the sensitivity of field-effect transistors (FET) using electrical signals.Despite FET-based molecular detection technology’s detecti
The Ministry of Food and Drug Safety has suspended the manufacturing of six drugs produced by Samyang Holdings for one month due to the violation of drug production management obligations and consignee management responsibilities.The ministry suspended six drugs -- three nicotine patches (Nicostop-1
GC Pharma applied for building and running a Biosafety Level 3 (BL3) research facility to the Korea Disease Control and Prevention Agency (KDCA) on Wednesday.The company said it is the first Korean drugmaker attempting to construct a BL3 facility.The biosafety level is an administrative standard use
Daewoong Pharmaceutical said Wednesday that the company and Hanall Biopharma would expand their “open collaboration” by jointly investing in the U.S. biopharmaceutical industry.Daewoong and Hanall have invested in NurrOn Pharmaceuticals' Series A round for developing novel therapies for Parkinson's
The Ministry of Food and Drug Safety said MSD withdrew all three of its Sinemet lineup of Parkinson's disease treatment -- Sinemet, Sinemet 25/100, and Sinemet-CR -- from Korea on Tuesday.According to industry experts, however, the withdrawal’s impact will be minimal as MSD had not marketed the prod
Countries with relatively high vaccination rates are pedaling back from preparations for a normal life and toughening quarantine controls due to the quick spread of the Delta variant.The U.S. Biden administration’s promise -- to get 70 percent of Americans vaccinated against Covid-19 for “summer of
inno.N said Wednesday that its IPO subscription competition rate for institutional investors reached 1,871 to 1, marking the highest level among biopharmaceutical companies listed on the Kosdaq market in the past 10 years. The company forecasted the demand for domestic and foreign investors between
GC Wellbeing said it has failed to meet the primary endpoint in phase 2a clinical trial of GCWB204, a drug candidate for cancer cachexia, but confirmed the development potential as a medication.The company aimed to license out its drug candidate, but the recent study results have might have pushed b
Korea Advanced Institute of Science and Technology (KAIST) and Samsung Electronics have co-developed a gas sensor platform, which diagnoses diseases from exhaled breath.The gas sensor platform is a technology that can monitor specific diseases in real-time by selectively sensing a tiny amount of bio
Daewoong Pharmaceutical said Wednesday that the company would speed up the entry into the Chinese market with its botulinum product, Nabota while releasing the topline results of its phase 3 clinical trials conducted in China.In the trial, researchers administered the same dose of Nabota or control
Korea's daily Covid-19 tally hit a new high on Wednesday, forcing the government to consider implementing stronger quarantine measures next week if the current distancing scheme fails to curb the virus spread.The country added 1,896 Covid-19 cases, including 1,823 local infections, raising the total
Janssen’s Covid-19 vaccine recipients reported the largest number of Covid-19 breakthrough infections among the fully vaccinated, the Korea Disease Control and Prevention Agency (KDCA) said in a regular briefing on Tuesday.A Covid-19 breakthrough infection refers to a Covid-19 case in a person two w
Prestige Biopharma, a company focusing on novel antibody therapies, said its trastuzumab biosimilar candidate, HD201 (Tuznue), showed an equivalent pharmacokinetic (PK) profile to Roche’s original drug Herceptin (ingredient: trastuzumab).The rate of treatment-emergent adverse events after administer
Researchers at St. Mary’s Seoul Hospital have developed a method to treat acute liver failure using 3D printing.Acute liver failure is a serious disease with a mortality rate of up to 80 percent if the patient does not receive liver transplantation at the time of onset. Therefore, there has been an
The Korea Pharmaceutical and Bio-pharma Manufacturers Association (KPBMA) said the revision of the Pharmaceutical Affairs Act to restrict generic drugs would be an inflection point to bring about a paradigm shift in the biopharmaceutical industry.The KPBMA made these and other points in its latest p
The FDA recently authorized Keytruda to be used as adjuvant therapy before and after surgery in patients with early triple-negative breast cancer (TNBC), defying the oncology drug advisory committee’s (ODAC) advice to reject MSD’s application.However, the controversy over whether the FDA made the ri
The Ministry of Food and Drug Safety designated TE Bios’ artificial, used to treat patients who have lost sight due to corneal damage, as the nation’s 12th innovative medical device.The ministry said Wednesday that it expects this innovative medical device designation to create new treatment opportu